SAN JUAN, Puerto Rico – Ozcorp Scientific, a biotech venture studio, proudly announces the official emergence of GENOS.BIO, marking its decisive step out of stealth-mode and into the limelight of pioneering bioinformatics solutions. Spearheaded by Dr. Osvaldo D. Rivera, a Bioinformatics Scientist and Cancer Cell Biologist, GENOS.BIO aims to revolutionize the landscape of bioinformatics services by providing accessible solutions to investigator's most complex projects and biological data hurdles. GENOS.BIO is positioned strategically within Puerto Rico, a recently designated Tech Hub to spur American innovation in biotechnologies, biopharmaceuticals and medical device manufacturing.
After an extensive run of academic training and industry work in bioinformatics, Dr. Rivera has meticulously crafted GENOS.BIO to provide full-service support in data processing, harmonization, analysis, visualization, and interpretation to wetlab-oriented investigators and research groups. "Our mission is clear: to become the premier service provider of bioinformatics by leveraging the much needed standardization of industry-standard tools and practices. Irrespective of team size, GENOS.BIO seeks to empower biotech innovators to transcend the limits of their research capacity. Embodying our ethos of 'Bioinformatics for Everyone', our commitment to fostering innovation and collaboration is unwavering." — expresses Dr. Rivera — "I decided to venture on building GENOS.BIO after having encountered several unmet needs in the sphere of experimental biology."
GENOS.BIO envisions executing upon transformative collaborations to ultimately drive biotechnological progress and adoption across fields such as genomics, transcriptomics, proteomics, and molecular dynamics. In the past year 2023, GENOS.BIO focused on establishing it's business foundations, acquiring local support and testing the market through word-of-mouth marketing. GENOS.BIO is proud to already service a handful of key projects at local private companies and research groups as well as investigators at the local public University of Puerto Rico Medical Science Campus. In the current year 2024, GENOS.BIO is fervently focused on amplifying its clientele base, forging new alliances through innovative private projects and academic collaborative research grants, as well as engineering bespoke software products designed to democratize access to bioinformatics capabilities. GENOS.BIO currently counts with strategic collaborations with well-established local SaaS development companies, solidifying its ability to build products quickly as needs evolve and funds are secured.
After an extensive run of academic training and industry work in bioinformatics, Dr. Rivera has meticulously crafted GENOS.BIO to provide full-service support in data processing, harmonization, analysis, visualization, and interpretation to wetlab-oriented investigators and research groups. "Our mission is clear: to become the premier service provider of bioinformatics by leveraging the much needed standardization of industry-standard tools and practices. Irrespective of team size, GENOS.BIO seeks to empower biotech innovators to transcend the limits of their research capacity. Embodying our ethos of 'Bioinformatics for Everyone', our commitment to fostering innovation and collaboration is unwavering." — expresses Dr. Rivera — "I decided to venture on building GENOS.BIO after having encountered several unmet needs in the sphere of experimental biology."
Investigators typically have backed up data that they wish to analyze, and are seeking cost-effective and timely solutions without needing to switch gears and learn new frameworks.
– Osvaldo D. Rivera, PhD
Founder & Head of Research
GENOS.BIO LLC
GENOS.BIO envisions executing upon transformative collaborations to ultimately drive biotechnological progress and adoption across fields such as genomics, transcriptomics, proteomics, and molecular dynamics. In the past year 2023, GENOS.BIO focused on establishing it's business foundations, acquiring local support and testing the market through word-of-mouth marketing. GENOS.BIO is proud to already service a handful of key projects at local private companies and research groups as well as investigators at the local public University of Puerto Rico Medical Science Campus. In the current year 2024, GENOS.BIO is fervently focused on amplifying its clientele base, forging new alliances through innovative private projects and academic collaborative research grants, as well as engineering bespoke software products designed to democratize access to bioinformatics capabilities. GENOS.BIO currently counts with strategic collaborations with well-established local SaaS development companies, solidifying its ability to build products quickly as needs evolve and funds are secured.
GENOS.BIO invites investigators, partners, and investors to join this transformative journey, as we redefine the landscape of bioinformatics service products.